Hiromi FurushimaPartner
Hiromi Furushima began her legal career in private practice, focusing on corporate and intellectual property matters at law firms. She later transitioned to in-house roles at global pharmaceutical companies, where she led the legal, intellectual property, and compliance departments and played an active role in corporate management. Her extensive experience includes the development and execution of IP strategies, management of IP litigation, criminal matters involving pharmaceutical regulatory violations, establishment of corporate governance frameworks, and negotiation of business development agreements. She currently also serves as an outside director and corporate auditor for biotech companies.
Background
Education
1994 University of Tokyo, Faculty of Law (LL.B.)
2001 Stanford Law School, Master of the Science of Law (J.S.M.)
Professional Experience
1994 The Legislative Bureau of the House of Representatives
1997 Koga & Partners
2000 Nishimura & Partners (now Nishimura & Asahi)
2006 Ito & Mitomi (now Morrison Foerster)
2011 Novartis Japan
(2012-2015) Head, Legal & Compliance Office, Sandoz K.K.
(2015-2022) Corporate Officer, General Counsel and Head of Legal & IP,
Novartis Pharma K.K.
2022 Director, International Legal, Alnylam Japan K.K.
2022- Outside Director, PRISM BioLab Co., Ltd.
2024- Outside Corporate Auditor, Cellusion Inc.
2025- Partner, Isshiki & Partners
Qualifications
1997 Admitted to the Japan Bar (Daini Tokyo Bar Association)
2003 Admitted to the California State Bar
- TOP
- /
- professionals
- /
- Hiromi Furushima